Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition
Publication
, Journal Article
Richman, B; Schulman, W
Published in: Loyola University Chicago Law Review
2017
Duke Scholars
Published In
Loyola University Chicago Law Review
Publication Date
2017
Volume
48
Start / End Page
787 / 819
Citation
APA
Chicago
ICMJE
MLA
NLM
Richman, B., & Schulman, W. (2017). Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition. Loyola University Chicago Law Review, 48, 787–819.
Richman, B., and W. Schulman. “Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition.” Loyola University Chicago Law Review 48 (2017): 787–819.
Richman B, Schulman W. Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition. Loyola University Chicago Law Review. 2017;48:787–819.
Richman, B., and W. Schulman. “Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition.” Loyola University Chicago Law Review, vol. 48, 2017, pp. 787–819.
Richman B, Schulman W. Pharmaceutical M&A Activity: Effects on Prices, Innovation, and Competition. Loyola University Chicago Law Review. 2017;48:787–819.
Published In
Loyola University Chicago Law Review
Publication Date
2017
Volume
48
Start / End Page
787 / 819